Pharmafile Logo

thinkemotive

ABPI London offices

Government crackdown on doctor-pharma payments

Physicians could face jail over accepting some industry gifts under new plans

- PMLiVE

Novartis buys rights to GSK’s Arzerra in MS for $1bn

Comes after a recent ‘asset swap’ between the firms worth $20bn 

From good intentions to unintended consequences

Pleiotropy in biology has direct analogues in the life science business

- PMLiVE

Oncology directions

With increasingly expensive cancer drugs, what price should be paid for innovation?

- PMLiVE

Boehringer Ingelheim’s John Pugh set for move to Accenture

Will take up London-based role in theconsultants' digital department

- PMLiVE

Monique Levy joins Google’s healthcare advisory board

Decision Resources analyst to help drive innovation

- PMLiVE

Jardiance is first diabetes drug to improve CV outcomes

Lilly/Boehringer drug could gain market share boost from new data

- PMLiVE

Intarcia’s diabetes implant beats Merck’s Januvia in trial

New injection-less therapy could revolutionise diabetes treatment

Celgene building

Myeloma market set to be $9bn by 2021

New research shows it will pushed by a growing prevalence of the disease

- PMLiVE

Valeant swoops on Sprout to claim female sexual disorder drug

Comes in the same week that firm gained US approval for its ‘little pink pill’

Two behavioural change contract wins for Hamell

Agency will work on segmentation and promotional projects

- PMLiVE

Lundbeck to cut 1,000 jobs in major restructure

Losses will be felt in its headquarter functions and commercial operations

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links